Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-α) production

Clinical and Experimental Immunology

Volumn 109, Issue 1, 1997, Pages 73-79

  Shirai, R ^a   Kadota, J ^a   Tomono, K ^a   Ogawa, K ^a   Iida, K ^a   Kawakami, K ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Granulocyte colony stimulating factor; Granulocytopenic mice; Macrophage; Pseudomonas aeruginosa; Tumour necrosis factor alpha

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GRAM NEGATIVE INFECTION; GRANULOCYTOPENIA; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030741808     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4211317.x     Document Type: Article

References (25)

1. Amura C, Fontan P, Sanjuan N, Sordelli D. The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudumonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopathol 1994; 73:261-6.
2. Griffith SJ, Nathan C, Selander RK, Chamberlain W, Gordon S, Kabins S, Weistein RA. The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis 1989; 160:1030-6.
3. Matsumoto M, Mutsubura S, Matsuno T, Tamura M, Hattori K, Nomura H, Ono M, Yokota T. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 1987; 55:2715-20.
4. Perlin E, Bang KM, Shah A, Hursey PD, Whittingam WL, Hashmi K, Campbell L, Kassim OO. The impact of pulmonary infections on the survival of lung cancer patients. Cancer 1990; 66:593-6.
5. Vogels MTE, van der Meer JWM. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother 1992; 36:1-5.
6. Boxer L, Huthinson R, Emerson S. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol 1992; 62:S39-S46.
7. Furuya N, Hirakata Y, Tomono K, Matsumoto T, Tateda K, Kaku M, Yamaguchi K. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates irom various clinical sources. J Med Microbiol 1993; 39:141-6.
8. Mizukane R, Hirakata Y, Kaku M et al. Comparative in vitro exo-enzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. Antimicrob Agents Chemother 1994; 38:528-33.
9. Kawakami K, Kohno S, Morikawa N, Kadota J, Saito A, Hara K. Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neoformans. Clin Exp Immunol 1994; 96:230-7.
10. Lister P, Gentry M, Preheim L. Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia. J Infect Dis 1993; 167:1131-7.
11. Kawakami K, Kohno S, Kadota J, Tohyama M, Teruya K, Kudeken N, Saito A, Hara K. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-γ and its protective effect against cryptococcal infection. Microbiol Immunol 1995; 39:135-43.
12. Quie PG, White JG, Holmes B, Good RA. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomalous disease of childhood. J Clin Invest 1967; 46:668-79.
13. Rozenberg-Arska M, Salters MEC, Strijp JAG, Geuze JJ, Verhoef J. Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes. Infect Immun 1985; 50:852-9.
14. Schuit KE. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun 1979; 24:932-8.
15. Trinkle LS, Wellhausen SR, Mcleish KR. A simultaneous flow cytometric measurement of neutrophil phagocytosis and oxidative burst in whole blood. Diagn Clin Immun 1987; 5:62-68.
16. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin R. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993; 61:3482-9.
17. Tamura M, Hattori K, Nomura H et al. Induction of neutrophilic granulocytosis in mice by administration of purified human active granulocyte colony-stimulating factor (G-CSF). Biochem Biophys Res Commun 1987; 142:454-60.
18. Welle K, Bonilla MA, Gillio AP et al. Recombinant human granulocyte colony stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987; 165:941-8.
19. Metcalf D, Nicola NA. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J Cell Physiol 1983; 116:198-206.
20. Platzer E, Welte K, Gabrilove J, Lu L, Harris P, Mertelsmann R, Moore MAS. Biological activities of human peuripotent hemopoietic colony-stimulating factor on normal and leukemic cells. J Exp Med 1985; 162:1788-801.
21. Souza LM, Boone TC, Gabrilove J et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232:61-65.
22. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelamann R, Moore MAS. Purification and biochemical characterization of human pluri-potent hematopoietic colony-stimulating factors. Proc Natl Acad Sci USA 1985; 82:1526.
23. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72:2074-81.
24. Shieh J, Peterson RHF, Moore MAS. Modulation of granulocyte colony-stimulating factor receptors on murine peritoneal exudate macrophages by tumor necrosis factor-α. J Immunol 1991; 146:2648-53.
25. Hebert JC, O'Reilly M, Yuenger K, Shatney L, Yoder DW, Barry B. Augmentation of alveolar macrophage phagocytic activity by granulocyte colony stimulating factor and interleukin-1: influence of splenectomy. J Trauma 1994; 37:909-12.